NR1H4 and Hepatic fibrosis: In cholestasis, the activation of FXR by excessive amounts of BA accumulated in the liver, is at a maximum, and it was demonstrated that administration of CDCA or DCA in their natural form, does not improve liver fibrosis in animal models of hepatic cholestasis [6].